argenx SE (NAS:ARGX)
$ 375.11 19.1 (5.37%) Market Cap: 22.36 Bil Enterprise Value: 18.06 Bil PE Ratio: 0 PB Ratio: 5.62 GF Score: 74/100

Q3 2020 argenx SE Earnings Call Transcript

Oct 22, 2020 / 12:30PM GMT
Release Date Price: $252.24 (-1.78%)
Operator

Good morning. My name is Rocco, and I will be your conference operator today. At this time, I would like to welcome everyone to the conference call. (Operator Instructions) Please also note, today's event is being recorded.

Thank you. I would now like to introduce Beth DelGiacco, Vice President of Investor Relations. You may begin your conference.

Beth DelGiacco
argenx SE - VP of IR

Thank you, Rocco. The press release was issued earlier today with our third quarter 2020 financial results and business update. This can be found on our website, along with the presentation for today's webcast.

Before we begin, I'd like to remind you on Slide 2 that forward-looking statements may be presented during this call. These may include statements about our future expectations, clinical developments, regulatory time lines, the potential success of our product candidates, financial projections and upcoming milestones. Actual results may differ materially from those indicated by these statements. argenx is not under any obligation to update statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot